183 related articles for article (PubMed ID: 11201833)
1. [Angiotensin converting enzyme-angiotensin II system, atherosclerosis, and angiotensin-converting enzyme inhibitors].
Aronov DM
Ter Arkh; 2000; 72(12):5-7. PubMed ID: 11201833
[No Abstract] [Full Text] [Related]
2. [Atherosclerosis. High ACE activity in plaque: risk of rupture!].
MMW Fortschr Med; 2001 Oct; 143(43):51. PubMed ID: 11715882
[No Abstract] [Full Text] [Related]
3. Renin-angiotensin system and atherothrombotic disease: from genes to treatment.
Jacoby DS; Rader DJ
Arch Intern Med; 2003 May; 163(10):1155-64. PubMed ID: 12767951
[TBL] [Abstract][Full Text] [Related]
4. Can angiotensin-converting enzyme inhibitors reverse atherosclerosis?
Higgins JP
South Med J; 2003 Jun; 96(6):569-79. PubMed ID: 12938784
[TBL] [Abstract][Full Text] [Related]
5. [Atherosclerosis].
Okura T; Higaki J
Nihon Rinsho; 2005 Mar; 63 Suppl 3():161-6. PubMed ID: 15813062
[No Abstract] [Full Text] [Related]
6. Diuretics are preferred over angiotensin II-converting enzyme inhibitors for initial therapy of uncomplicated hypertension.
Campese VM
Am J Kidney Dis; 2007 Aug; 50(2):197-202. PubMed ID: 17660021
[No Abstract] [Full Text] [Related]
7. [Renin-angiotensin system: current view].
del Río A
Med Clin (Barc); 1991 Jun; 97(1):17-20. PubMed ID: 1649939
[No Abstract] [Full Text] [Related]
8. Diuretics are preferred over angiotensin II-converting enzyme inhibitors for initial therapy of uncomplicated hypertension.
Grimm R
Am J Kidney Dis; 2007 Aug; 50(2):188-96. PubMed ID: 17660020
[No Abstract] [Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors in patients with atherosclerosis and preserved left ventricular function: clinical outcomes.
Pepine C
Can J Cardiol; 1998 Jul; 14 Suppl D():23D-26D. PubMed ID: 9713427
[No Abstract] [Full Text] [Related]
10. [Intervention in the renin-angiotensin and kallikrein-kinin systems. Pharmacologic basis of the action of ACE inhibitors].
Linz W; Busch AE
Pharm Unserer Zeit; 2003; 32(1):18-22. PubMed ID: 12577756
[No Abstract] [Full Text] [Related]
11. Is angiotensin receptor blockade antithrombotic?
Lim HS; Lip GY
Arch Intern Med; 2003 Dec 8-22; 163(22):2790-1; author reply 2792-3. PubMed ID: 14662638
[No Abstract] [Full Text] [Related]
12. Renin-angiotensin system and atherosclerosis.
Grote K; Drexler H; Schieffer B
Nephrol Dial Transplant; 2004 Apr; 19(4):770-3. PubMed ID: 15031327
[No Abstract] [Full Text] [Related]
13. Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosis.
AbdAlla S; Lother H; Langer A; el Faramawy Y; Quitterer U
Cell; 2004 Oct; 119(3):343-54. PubMed ID: 15507206
[TBL] [Abstract][Full Text] [Related]
14. [Anti-ischemic and infarction-reducing effects of angiotensin-converting enzyme inhibitors].
Landmark K; Aursnes I
Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1923-6. PubMed ID: 11488184
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitors of angiotensin-converting enzyme and processus of intima proliferation in atherosclerosis].
Rolland PH; Friggi A; Bodard H; Garçon D; Charpiot P; Barlatier A; Calaf R; Faye MM; Mercier C; Luccioni R
Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():167-9. PubMed ID: 1285698
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction: its pathogenic role in atherosclerosis and its reversal by ACE inhibition.
Neutel JM
Postgrad Med; 2000 Oct; 108(5 Suppl):4-11. PubMed ID: 19667535
[TBL] [Abstract][Full Text] [Related]
17. Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway?
Husain A; Li M; Graham RM
Circ Res; 2003 Jul; 93(2):91-3. PubMed ID: 12881473
[No Abstract] [Full Text] [Related]
18. [Association between angiotensin converting enzyme I/D polymorphism and high-sensitivity C-reactive protein in type 2 diabetic patients with atherosclerosis treated with ramipril].
Wang L; Zhou YL; Lin SG
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):691-5. PubMed ID: 15958311
[TBL] [Abstract][Full Text] [Related]
19. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
20. The physiological significance of the alternative pathways of angiotensin II production.
Kramkowski K; Mogielnicki A; Buczko W
J Physiol Pharmacol; 2006 Dec; 57(4):529-39. PubMed ID: 17229979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
